Jane Street
SPRY icon

Jane Street’s ARS Pharmaceuticals SPRY Stock Holding History

Jane Street’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,700
Closed -$134K – 13035
2026
Q1 		$134K Buy
16,700
+4,000
+31% +$38.3K ﹤0.01% 10470
2025
Q4 		$148K Buy
+12,700
New +$124K ﹤0.01% 9940
2025
Q2 		– Sell
-39,300
Closed -$494K – 10810
2025
Q1 		$494K Buy
39,300
+14,400
+58% +$173K ﹤0.01% 6882
2024
Q4 		$263K Buy
+24,900
New +$349K ﹤0.01% 7952
2024
Q3 		– Sell
-190,200
Closed -$1.62M – 10359
2024
Q2 		$1.62M Buy
+190,200
New +$1.69M ﹤0.01% 4868

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $446M AUM 84.15% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Jane Street's SPRY Position: Q2 2026 in Review

Jane Street opened a new position in ARS Pharmaceuticals (SPRY) in Q2 2026: 17,997 shares worth $144K. The stake represents ﹤0.01% of the portfolio and ranks #10378 among its holdings. This is a return to the name: Jane Street previously reported a position in SPRY as recently as Q3 2025.

Jane Street first reported a position in SPRY in Q4 2020 and has held it in 14 quarters since. The position peaked at $2.43M in Q3 2025. 208 funds tracked by Wall St. Rank hold SPRY as of Q2 2026.

  • Jane Street held 17,997 shares of ARS Pharmaceuticals worth $144K as of Q2 2026.
  • ARS Pharmaceuticals was a new Jane Street position in Q2 2026.
  • ARS Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10378 holding.
  • Jane Street first reported a position in ARS Pharmaceuticals in Q4 2020 and has held it in 14 quarters since.
  • Jane Street's ARS Pharmaceuticals position peaked at $2.43M in Q3 2025.
  • 208 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.